Friday, April 5, 2024

A potential thyroid carcinoma

Ultrasound imaging findings:

1. Hypoechoic nodule (5mm x 4mm) in left lobe: Indicates a potentially abnormal growth within the thyroid gland.
2. Microcalcifications present: Suggests the presence of calcified structures within the nodule, which can be associated with malignancy.
3. Mass is taller than wide: This aspect ratio is often associated with a higher likelihood of malignancy.
4. Possible breach of anterior thyroid capsule: Suggests potential invasion into surrounding tissues, another concerning feature.
5. Poorly vascular. Possibly due to small size of lesion. 

For more on this topic visit:

Prognosis and Management:

1. TIRADS Score: The Thyroid Imaging Reporting and Data System (TIRADS) score helps in risk stratification of thyroid nodules.  The nodule likely falls into a higher TIRADS category TIRADS V, indicating a higher risk of malignancy.
2. Biopsy: Given the concerning features, a fine needle aspiration biopsy (FNAB) is recommended to obtain tissue samples for further evaluation.
3. Follow-up Imaging: Depending on the biopsy results, further imaging or surveillance may be necessary to monitor the nodule's progression.
4. Treatment: Treatment options can range from surgical removal of the nodule or thyroid gland (thyroidectomy) to radioactive iodine therapy or hormone suppression therapy, depending on the final diagnosis.

Friday, March 22, 2024

Multiple vesical calculi with complications

Ultrasound Imaging Findings:

1. Urinary Bladder Calculi:
   - Two large calculi, each measuring 2.5 cms, detected within the urinary bladder.
   - Visualized as hyperechoic foci with evident acoustic shadowing.
   - Potential for obstruction of urine flow due to their size and location.
   - Further evaluation needed to assess composition and determine appropriate management.

2. Bilateral Mild Hydronephrosis:
   - Bilateral mild dilation observed in the renal pelvis and calyces.
   - Indicative of impaired drainage or obstruction, possibly due to bladder calculi.
   - Progression to renal impairment is possible if left untreated.
   - Continuous monitoring required to assess for changes in hydronephrosis severity.

3. Grade 1 Prostatomegaly:
   - Enlargement of the prostate gland noted, graded as mild.
   - May contribute to urinary symptoms and exacerbate obstruction caused by bladder calculi.
   - Management strategies should address both prostatomegaly and associated urinary tract issues.
   - Consideration of treatment modalities such as alpha-blockers and TURP warranted.
For more on this topic visit:


- Without intervention, there is a risk of recurrent urinary tract infections, worsening hydronephrosis, and renal dysfunction.
- Prognosis can be favorable with timely and appropriate management strategies.


1. Medical Management:
   - Symptomatic relief: Utilization of analgesics for pain management.
   - Antibiotic therapy: If urinary tract infection is present or suspected.
   - Pharmacological interventions: Consideration of alpha-blockers to alleviate symptoms of prostatomegaly.

2. Surgical Intervention:
   - Endoscopic procedures: Options include lithotripsy for bladder calculi fragmentation and TURP for prostatomegaly-related obstruction.
   - Ureteral stent placement: Temporary measure to relieve obstruction in cases of severe hydronephrosis.

3. Follow-up:
   - Regular monitoring of renal function and urinary symptoms to assess treatment efficacy.
   - Repeat ultrasound examinations to evaluate resolution of hydronephrosis and status of bladder calculi post-intervention.

4. Lifestyle Modifications:
   - Promotion of adequate hydration to prevent stone formation.
   - Dietary adjustments: Guidance on avoiding foods high in oxalates and maintaining a balanced diet.
   - Pelvic floor exercises: Encouragement for improving bladder emptying and managing symptoms of prostatomegaly.

Comprehensive evaluation and a multidisciplinary approach are essential in managing adult male patients with urinary bladder calculi, bilateral mild hydronephrosis, and grade 1 prostatomegaly. Targeted interventions can mitigate complications and optimize long-term outcomes for these patients.

Saturday, March 16, 2024

Early fetal brain at 9 weeks

#Fetal Rhombencephalon

The fetal rhombencephalon, also sometimes referred to as the embryonic rhombencephalon or cystic rhombencephalon, is a structure visible during early fetal development on ultrasound scans between 8 and 10 weeks gestational age (GA). It's important to understand that this finding is entirely normal and should not be mistaken for a developmental abnormality. 

The rhombencephalon itself is the hindbrain region of the developing brain. It eventually gives rise to important structures including the:

* Medulla oblongata
* Pons
* Cerebellum

What is seen on ultrasound during this timeframe isn't actually the rhombencephalon tissue itself, but rather a fluid-filled space called the rhomboid fossa. This fossa is part of the developing rhombencephalon complex.  
[Ultrasound Images of Rhombencephalon brain]

# Fetal Diencephalon:

The diencephalon is another region of the developing brain that appears earlier than the rhombencephalon. This structure forms around week 4 of gestation and develops into parts of the brain crucial for vision, hormone regulation, and motor control. Some of the structures that arise from the diencephalon include:

* Thalamus
* Hypothalamus
* Pituitary gland

The diencephalon is not typically visualized directly on prenatal ultrasound because it is a smaller structure and doesn't have a distinct sonographic appearance. 

Here's a table summarizing the key points about the fetal rhombencephalon and diencephalon:

For interesting ultrasound imaging cases in ebook format:
Assorted ultrasound cases atlas

For Indian readers:

Friday, March 15, 2024

What is liver shear wave elastography?

Liver shear wave elastography (SWE) is a non-invasive imaging technique used to assess liver fibrosis and stiffness. Here's a detailed overview of the procedure and interpretation:

1. **Procedure:
   - The patient lies comfortably on their back with their right arm raised above their head.
   - A trained technician places a transducer probe on the skin over the right lobe of the liver.
   - The transducer emits low-frequency mechanical waves (shear waves) into the liver tissue.
   - The speed of these shear waves is measured as they propagate through the liver.
   - The measurement is typically done in either the supine or the intercostal position.
   - The procedure is painless and usually takes only a few minutes.

2. **Interpretation:
   - Liver stiffness is measured in kilopascals (kPa). A higher stiffness indicates more fibrosis.
   - The results are displayed as a color-coded map overlaid on a B-mode ultrasound image.
   - Different cutoff values are used to categorize liver fibrosis stages (e.g., F0-F4) based on liver stiffness measurements.
   - Interpretation often involves comparing the stiffness measurements with established cutoffs and correlating them with other clinical data (e.g., liver function tests, imaging findings).

Grading of liver fibrosis:
 Fibrosis is graded using a scale typically ranging from F0 to F4, with F0 indicating no fibrosis and F4 indicating cirrhosis. Here's a detailed breakdown:

1. F0 - No fibrosis: This stage indicates that there is no detectable fibrosis in the liver. The liver tissue is considered healthy and normal.

2. F1 - Mild fibrosis: At this stage, there is minimal fibrosis present, usually confined to the portal areas of the liver. It doesn't affect liver function significantly.

3. F2 - Moderate fibrosis: Fibrosis is more widespread within the liver, extending beyond the portal areas but not yet causing significant architectural distortion.

4. F3 - Severe fibrosis: Also known as advanced fibrosis, F3 indicates extensive scarring of the liver tissue, with bridging fibrosis starting to form between portal and central areas of the liver.

5. F4 - Cirrhosis: This is the most advanced stage of liver fibrosis. Cirrhosis involves extensive scarring and nodules in the liver, leading to significant distortion of liver architecture and impaired liver function. It's irreversible and can lead to complications such as portal hypertension, liver failure, and hepatocellular carcinoma.

These grades help clinicians assess the extent of liver damage and guide treatment decisions. Early detection and management of liver fibrosis are crucial to prevent progression to cirrhosis and its associated complications.

3. Clinical Applications:
   - Liver SWE is commonly used to assess liver fibrosis in patients with chronic liver diseases such as hepatitis B and C, non-alcoholic fatty liver disease (NAFLD), and alcoholic liver disease.
   - It helps clinicians monitor disease progression, guide treatment decisions, and assess treatment response.
   - SWE can also be used to evaluate focal liver lesions, such as hepatocellular carcinoma, by assessing their stiffness compared to the surrounding liver tissue.

4. Advantages:
   - Non-invasive: Unlike liver biopsy, SWE does not require tissue sampling.
   - Quick and easy: The procedure is rapid and well-tolerated by patients.
   - Repeatable: SWE can be performed serially to monitor changes in liver stiffness over time.

5. Limitations:
   - Operator dependence: Proper technique and operator experience are crucial for obtaining accurate measurements.
   - Obesity and ascites: These conditions can affect the accuracy of SWE measurements.
   - Variability: Stiffness measurements can vary depending on factors such as patient positioning and the location of measurements within the liver.

Summary: liver shear wave elastography is a valuable tool for assessing liver fibrosis non-invasively, providing clinicians with important information for patient management and treatment decisions.

Saturday, March 9, 2024

Atrial flutter on spectral Doppler ultrasound

In atrial flutter with rapid ventricular response, the spectral Doppler ultrasound waveform of lower limb arteries would typically exhibit irregularity in the timing of the waves, reflecting the irregular ventricular contraction pattern. Additionally, there would be variable peak systolic velocities (PSV), with fluctuations in velocity amplitude corresponding to the varying ventricular response rates. This variability in PSV is indicative of the erratic ventricular contraction pattern associated with atrial flutter. Overall, the waveform would demonstrate irregularity in timing, variable PSV, and potentially altered diastolic flow characteristics.

1. Depends on the underlying cause and comorbidities.
2. Rapid ventricular response in atrial flutter may lead to hemodynamic instability and increase the risk of thromboembolic events.
3. Prompt management is crucial to prevent complications.

1. Rate control: Administer medications such as beta-blockers, calcium channel blockers, or digoxin to slow ventricular response and stabilize heart rate.
2. Anticoagulation: Initiate anticoagulant therapy to prevent thromboembolic events, especially in patients with additional risk factors such as atrial fibrillation.
3. Rhythm control: Consider cardioversion if rate control strategies are ineffective or if the patient remains symptomatic.
4. Address underlying causes: Treat any underlying conditions contributing to atrial flutter, such as electrolyte imbalances or structural heart disease.
5. Monitor closely: Regular follow-up evaluations to assess response to treatment, adjust medications as needed, and monitor for complications.

Download this great ebook on arterial Doppler ultrasound 

Saturday, February 24, 2024

Large renal cortical cyst, sonography

* Ultrasound:
    * Anechoic (fluid-filled) lesion with well-defined margins and a thin wall.
    * Posterior acoustic enhancement (increased echogenicity behind the cyst).
    * Few, thin septa may be present (normal in up to 5% of simple cysts). In this case, no septae seen. 
    * No internal echoes or echogenic debris (suggestive of complexity).

* **Color Doppler:
    * Avascular (no blood flow within the cyst).

For more on this topic visit:


* Simple renal cysts, like the one described here, are generally benign and have an excellent prognosis.
* The size of the cyst itself does not necessarily indicate malignancy.
* Long-term follow-up is usually not required unless the cyst grows significantly or causes symptoms.


* Most simple renal cysts do not require treatment.
* Observation is typically the recommended approach.
* If the cyst causes pain, infection, or other complications, intervention might be considered.
    * Options include aspiration (needle drainage), sclerotherapy (injection of a substance to shrink the cyst), or surgery in rare cases.

Remember, this information is for educational purposes only and should not be interpreted as medical advice.